U.S., Feb. 10 -- An application to own the trademark for 'INFLAMOSTAT' has been filed on Mar. 06, 2024.
Owner(s):
3Helix Inc.; 675 Arapeen Drive, Suite 302, , Utah
Goods and/or Services:
For: Synthetic and collagen peptides for use in the fields of medical diagnostics and biotechnology, namely, for the treatment of immune mediated diseases, namely, dermal, eye, systemic, inflammatory, autoimmune, rheumatic, liver, and gastrointestinal conditions and diseases; pharmaceutical preparations for use in the fields of medical diagnostics and biotechnology, namely, topical drugs for the treatment of immune mediated diseases, namely, dermal, eye, systemic, inflammatory, autoimmune, rheumatic, liver, and gastrointestinal conditions and diseases; ...